+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Vindesine"

Vinca Alkaloid Compounds Market - Global Forecast 2025-2030 - Product Thumbnail Image

Vinca Alkaloid Compounds Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 199 Pages
  • Global
From
From
Microtubule Inhibitor Chemotherapy Drugs Market Report 2025 - Product Thumbnail Image

Microtubule Inhibitor Chemotherapy Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Vindesine Sulfate API Market - Global Forecast 2025-2030 - Product Thumbnail Image

Vindesine Sulfate API Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 194 Pages
  • Global
From
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Vindesine is an oncology drug used to treat a variety of cancers, including breast, ovarian, and lung cancer. It is a semi-synthetic vinca alkaloid, derived from the Madagascar periwinkle plant, and works by inhibiting the growth of cancer cells. Vindesine is typically administered intravenously, and is often used in combination with other chemotherapy drugs. Vindesine is available in many countries around the world, and is marketed by a number of pharmaceutical companies. It is typically prescribed by oncologists, and is available in both generic and branded forms. Companies in the Vindesine market include Pfizer, Novartis, Sanofi, Merck, and Bristol-Myers Squibb. Show Less Read more